(NASDAQ:EVOK), SOLANA BEACH, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI(R) (metoclopramide) nasal spray, today announced that U.S. Patent No. 12,377,064 covering the use of GIMOTI(R) (metoclopramide) nasal spray in patients with moderate to […]
(NasdaqGM:SKYE), SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it will participate in the following upcoming investment and medical conferences: Investment Conferences Cantor Global Healthcare Conference (New York)Fireside Chat
(NASDAQ:BCRX), RESEARCH TRIANGLE PARK, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the Cantor Global Healthcare Conference in New York on Thursday, September 4, 2025, at 9:45 a.m. ET. The link to the live audio webcast and replay of the presentation may
(NasdaqGM:CSTL), FRIENDSWOOD, Texas, Aug. 21, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at Baird's 2025 Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 10:15 a.m. Eastern time. A
BioCryst to Present at Upcoming Investor Conference GlobeNewswire August 21, 2025 RESEARCH TRIANGLE PARK, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the Cantor Global Healthcare Conference in New York on Thursday, September 4, 2025, at 9:45 a.m. ET. The link to
Evoke Pharma Announces Listing of New GIMOTI(R) Patent in FDA Orange Book GlobeNewswire August 21, 2025 SOLANA BEACH, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI(R) (metoclopramide) nasal spray, today announced that U.S. Patent
Mobilicom's Ground Control Stations Selected by One of Israel's Largest Defense Contractors to Support Remote Control Weapons Systems GlobeNewswire August 21, 2025 Marks the latest product integration and expansion with one of Mobilicom's long-term customers, a global leader in defense, aerospace, and commercial markets The RCWS platform is expected to be sold and deployed in
Regenx Provides Bi-Weekly Update on Status of Management Cease Trade Order GlobeNewswire August 21, 2025 EDMONTON, Alberta, Aug. 21, 2025 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Corporation” or “Regenx“) (CSE: RGX) (OTCQB: RGXT) (FSE: YRS WKN: A2DSW3) is providing this bi-weekly update on the status of the management cease trade order granted on July
Beamr to Present at the H.C. Wainwright 27th Annual Global Investment Conference GlobeNewswire August 21, 2025 Herzliya Israel, Aug. 21, 2025 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced that it will present virtually at the H.C. Wainwright 27th Annual Global Investment Conference which is
Quantum BioPharma Announces Corporate Updates GlobeNewswire August 21, 2025 TORONTO, Aug. 21, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company“), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders